Skip to main content
. 2018 Jul 9;13(7):e0198047. doi: 10.1371/journal.pone.0198047

Table 5. Average daily cigarette consumption at one-year follow-up by ENDS use among non-quitters for all baseline smokers (N = 680*) and baseline daily smokers (N = 543).

Average Cigarettes per Day Smoked
ENDS Use n wt. Mean 95% CI Adj. Mean Difference 95% CI
Model 7a: Baseline ENDS Use
No ENDS use at Baseline (Reference) 469 12.2 11.03, 13.36 REF -
ENDS Use at Baseline 211 10.81 9.04, 12.57 -0.56 -1.68, 0.56
Model 7b: Baseline ENDS Use (Daily Smokers)
No ENDS use at Baseline (Reference) 386 14.11 12.91, 15.31 REF -
ENDS Use at Baseline 157 12.76 10.62, 14.91 -0.99 -2.26, 0.29
Model 8a: Any ENDS Use
No ENDS Use (Reference) 382 12.02 10.68, 13.35 REF -
Any ENDS Use 298 11.51 10.06, 12.95 -0.03 -1.01, 0.94
    ENDS use at baseline & follow-up 113 8.36 6.53, 10.19 -0.81 -2.27, 0.64
    ENDS use initiated after baseline 45 10.28 7.40, 13.15 -0.07 -2.37, 2.23
    ENDS use but discontinued before follow-up 140 14.87 12.93, 16.80 0.51 -0.71, 1.74
Model 8b: Any ENDS Use (Daily Smokers)
No ENDS Use (Reference) 318 13.94 12.52, 15.36 REF -
Any ENDS Use 225 13.49 11.91, 15.07 -0.32 -1.42, 0.78
    ENDS use at baseline & follow-up 78 9.79 7.36, 12.23 -1.48 -3.19, 0.23
    ENDS use initiated after baseline 34 13.02 10.71, 15.33 -0.27 -2.88, 2.34
    ENDS use but discontinued before follow-up 113 16.19 14.27, 18.10 0.39 -0.98, 1.76

ENDS = electronic nicotine delivery systems; Denom = denominator; Num = numerator; wt. = weighted; CI = confidence interval; AOR = adjusted odds ratio; REF = reference.

Statistical adjustments are made for baseline perceptions of addiction, cravings to smoke, cigarettes per day smoked, number of years having smoked, past year quit attempts, use of nicotine replacement theory, poly-use of other combusted tobacco, smoker regret, socio-demographics (age, gender, race/ethnicity, education, household income, MSA status, marital status, sexual orientation, US Census region, children in household), perceived physical health, presence of asthma, chronic bronchitis or COPD, receiving psychological therapy, alcohol consumption, and past year participation in other tobacco studies through GfK.

*See S5 Table for results among all baseline smokers based on multiply imputed data.

Exploratory pairwise comparisons among ENDS exposure groups were conducted. None of these comparisons was statistically significant.